Dr. Benjamin Levy, Mount Sinai Health Systems, compares zoledronic acid and denosumab, two agents used for treatment of bone metastases in lung cancer.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
